Prudential expands preferred healthcare network in partnership with Icon Cancer Centre
Werte in diesem Artikel
Prudential customers now have access to ten cancer clinics, including a one-stop integrated cancer centre at Icon Cancer Centre SingaporeHONG KONG SAR - Media OutReach Newswire - 14 November 2024 - Prudential plc ("Prudential") and Icon Cancer Centre Singapore ("Icon") today announced a partnership that will provide Prudential's health customers in Singapore and Indonesia access to outpatient cancer treatment, on a cashless basis[1], at Icon's clinics in Singapore.
Treatments that are covered include chemotherapy, immunotherapy, targeted therapy, radiotherapy and surgical oncology*. In addition to prescribed cancer drugs, Icon's clinics can provide Prudential customers with access to a team of leading oncologists and haematologists. Customers based in Singapore can also make use of Icon's diagnostic screening facility. Prudential's customers in Indonesia who wish to receive their treatment overseas can choose any preferred clinic from the Icon Cancer Centre network in Singapore without having to pay out of pocket. In Southeast Asia, more than 2.3 million people are diagnosed with cancer each year1. In Singapore, cancer incidence rates have risen by almost 28 per cent over the last 50 years2. For Indonesia, the same trend is observed with a 17 per cent increase of new diagnoses from 2020 to 20223. "At Prudential, our focus is on providing affordable access to quality care for our customers. Receiving a cancer diagnosis can be life-changing and overwhelming, and questions about where to seek treatment and its cost only add to patients' anxiety. Integrating Icon into Prudential's preferred partnership network enables our customers to easily access a specialist cancer centre with proven expertise in treating many types of cancers without having to pay out of pocket," said Arjan Toor, CEO, Health at Prudential plc. "We have launched this partnership for the benefit of our customers in Singapore and Indonesia, two priority markets for our Health business, where we see growing demand for health insurance as well as an increasing volume of medical claims. We are looking to extend this access to other markets so more of our customers can benefit from high-quality cancer care," said Toor. "Icon is pleased to partner with Prudential to enhance access to high-quality cancer care, diagnosis, and treatment. Together, we are dedicated to making a lasting impact on cancer care and improving outcomes for patients. This partnership will help ease the burden for patients and their families, relieving some of the stress that comes with a cancer diagnosis and allowing them to focus on their treatment and wellbeing," said Serena Wee, CEO, Icon Cancer Centre – ASEAN. [1] In Singapore, customers holding the PRUExtra Premier, PRUExtra Premier CoPay and PRUExtra Preferred CoPay plans are eligible under PRUPanel Connect (PPC) for cashless medical services at Icon through an enhanced electronic letter of guarantee or pre-authorisation. For terms and conditions, click here: PRUPanel Connect Terms & Conditions | Prudential Singapore Notes: *Diagnostics, drugs, and other services unrelated to outpatient chemotherapy and/or radiotherapy treatment will require payment at Icon Cancer Centre. 1World Health Organisation 2National Registry of Diseases Office 32020 World Health Organisation Cancer Country Profile and 2022 World Health Organisation Indonesia Factsheet Hashtag: #Prudential #Icon The issuer is solely responsible for the content of this announcement. About Prudential plcPrudential plc provides life and health insurance and asset management in 24 markets across Asia and Africa. Prudential's mission is to be the most trusted partner and protector for this generation and generations to come, by providing simple and accessible financial and health solutions. The business has dual primary listings on the Stock Exchange of Hong Kong (2378) and the London Stock Exchange (PRU). It also has a secondary listing on the Singapore Stock Exchange (K6S) and a listing on the New York Stock Exchange (PUK) in the form of American Depositary Receipts. It is a constituent of the Hang Seng Composite Index and is also included for trading in the Shenzhen-Hong Kong Stock Connect programme and the Shanghai-Hong Kong Stock Connect programme. About IconIcon Group Icon Cancer Centre – SingaporeIcon Cancer Centre is a leading private cancer care provider delivering a holistic approach to cancer care. Icon Cancer Centre is part of Icon Group, a global cancer care provider with more than 45 centres globally. Icon Cancer Centre has six specialist clinics in Singapore and a dedicated health screening clinic. With a prominent and experienced team of medical oncologists, radiation oncologists, haematologists, paediatric haematologist-oncologists, palliative care specialists, general practitioners and visiting surgical oncologists, Icon provides end-to-end cancer care from screening and diagnosis, through to treatment and beyond. News Source: Prudential plc
14/11/2024 Dissemination of a Financial Press Release, transmitted by EQS News. |
Ausgewählte Hebelprodukte auf Prudential
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Prudential
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Prudential plc
Analysen zu Prudential plc
Datum | Rating | Analyst | |
---|---|---|---|
05.08.2024 | Prudential Hold | Deutsche Bank AG | |
12.09.2023 | Prudential Buy | UBS AG | |
04.04.2023 | Prudential Buy | Jefferies & Company Inc. | |
21.03.2023 | Prudential Overweight | JP Morgan Chase & Co. | |
06.03.2023 | Prudential Buy | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
12.09.2023 | Prudential Buy | UBS AG | |
04.04.2023 | Prudential Buy | Jefferies & Company Inc. | |
21.03.2023 | Prudential Overweight | JP Morgan Chase & Co. | |
06.03.2023 | Prudential Buy | UBS AG | |
26.01.2023 | Prudential Overweight | JP Morgan Chase & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
05.08.2024 | Prudential Hold | Deutsche Bank AG | |
08.09.2021 | Prudential Neutral | JP Morgan Chase & Co. | |
11.08.2021 | Prudential Neutral | JP Morgan Chase & Co. | |
30.06.2021 | Prudential Neutral | JP Morgan Chase & Co. | |
13.05.2021 | Prudential Neutral | JP Morgan Chase & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
31.10.2019 | Prudential Sell | Société Générale Group S.A. (SG) | |
15.03.2017 | Prudential Underweight | JP Morgan Chase & Co. | |
21.02.2017 | Prudential Underweight | JP Morgan Chase & Co. | |
05.01.2017 | Prudential Underweight | JP Morgan Chase & Co. | |
06.09.2016 | Prudential Underweight | JP Morgan Chase & Co. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Prudential plc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen